Skip to main content
. 2017 Aug 10;18(8):1737. doi: 10.3390/ijms18081737
ADRs Adverse drug reactions
aAEDs Aromatic antiepileptic drugs
AGEP Acute Generalized Exanthematous Pustulosis
ALDEN Algorithm of drug causality for epidermal necrolysis
ALP Allopurinol
BrdU FITC Bromodeoxyuridine fluorescein isothiocyanate assay
CBA Cytokine beads array
CD Cluster of differentiation
CTLA4 Cytotoxic T-lymphocyte-associated protein 4
DHRs Drug hypersensitivity reactions
DRESS Drug Rash with Eosinophilia and Systemic Symptoms
ELISA Enzyme-linked immunosorbent assay
ELISpot Enzyme-linked immunospot assay
FACS Fluorescence-activated cell sorting
GrB Granzyme B
Grl Granulysin
HLA Human Leukocyte Antigens
ICM Iodinated contrast media
IFNg Interferon γ
IL Interleukin
LTT Lymphocyte transformation test
NA Not applicable
ND Not determined
OXP Oxpurinol
PBMC Peripheral blood mononuclear cells
PD-L1 Programmed cell death-ligand 1
RegiSCAR Registry of severe cutaneous adverse drug reactions
ROC Receiver operator characteristic curve
RT-PCR Reverse transcription polymerase chain reaction
SCARs Severe cutaneous adverse drug reactions
sFasL Soluble factor-related apoptosis ligand
SJS Stevens–Johnson Syndrome
SMX Sulfamethoxazole
TCR T-cell receptor
TEN Toxic Epidermal Necrolysis
TNFa Tumor necrosis factor α
TRM Trimethoprim